Test Price
1,200 AED✅ Home Collection Available
Comprehensive Newborn Screening Panel in UAE | 1200 AED | 2026 DHA Guidelines
تحليل فحص حديثي الولادة الشامل في الإمارات | 1200 درهم | معتمد من هيئة الصحة بدبي
Methodology: Tandem Mass Spectrometry (TMS) • Fluoroimmunoassay (FEIA) • Capillary Electrophoresis | ISO 9001:2015 Certified
Executive Summary | ملخص تنفيذي
يُعد فحص حديثي الولادة الشامل أداة تشخيصية متقدمة للكشف المبكر عن أمراض التمثيل الغذائي الوراثية لدى الأطفال حديثي الولادة في دولة الإمارات العربية المتحدة. يتم إجراء هذا الفحص وفقاً لأعلى معايير الجودة العالمية ISO 9001:2015 وتحت إشراف هيئة الصحة بدبي، مما يضمن دقة تشخيصية تصل إلى 99.9% باستخدام تقنيات متطورة تشمل قياس الطيف الكتلي الترادفي (TMS) والمقايسة المناعية الفلورية (FEIA) والهجرة الكهربائية الشعرية.
- ●Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO-Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ●Premium Logistics: Paid Hospital-Grade Home Collection via ISO-Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy — available 8 AM to 11 PM daily.
- ●Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by qualified specialists.
- ●Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Clinical Overview
The Comprehensive Newborn Screening Panel is a state-of-the-art diagnostic assay designed to detect over 50 inborn errors of metabolism (IEMs) from a single heel-prick blood sample collected on filter paper — enabling life-saving early intervention within the critical neonatal window. يكتشف هذا الفحص الشامل أكثر من 50 اضطراباً استقلابياً وراثياً لدى حديثي الولادة.
| Feature | Our Test — Comprehensive Panel | Closest Alternative — Basic Screening |
|---|---|---|
| Precision & Methodology | Tandem Mass Spectrometry (TMS) + Fluoroimmunoassay (FEIA) + Capillary Electrophoresis — ultra-high sensitivity | Fluorometric or colorimetric methods only — limited analyte detection |
| Conditions Detected | 50+ IEMs including PKU, MSUD, congenital hypothyroidism, CAH, galactosemia, and fatty acid oxidation disorders | 5–10 core conditions only |
| Turnaround Time | Next-day reporting (Sample Mon/Wed/Fri by 9 AM) | 3–7 business days |
| Regulatory Compliance | DHA-Licensed • ISO 9001:2015 • UAE Federal Decree-Law No. 41 of 2024 Compliant | Variable; may lack UAE-specific accreditation |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy
Consultant Pediatrician & Neonatologist • DHA License No. 61713011
As a neonatologist with extensive experience in the UAE healthcare system, I want parents to know that newborn screening is one of the most impactful preventive tools we have — these tests can identify treatable metabolic conditions days before symptoms ever appear. Every screening result, whether normal or flagged, must be clinically correlated with your baby's feeding patterns, weight gain, and overall examination findings by your pediatrician. Please remember that this panel is a screening tool, not a definitive diagnosis, and any abnormal result will be followed by confirmatory testing and specialist consultation at no delay.
⚠ Medication Warning: Do not discontinue any prescribed medication or supplement administered to your newborn without consulting your attending neonatologist or pediatrician. Clinical details and complete drug history must accompany the screening sample to ensure accurate interpretation.
Safety Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Collect)
- Infant has received a blood transfusion within 48 hours prior to screening — may invalidate metabolic analyte levels.
- Infant is currently on Total Parenteral Nutrition (TPN) — exogenous amino acids interfere with TMS interpretation.
- Insufficient blood volume — all three spots on the filter paper must be fully saturated with free-flowing heel-prick blood.
- Sample frozen during transport — must be shipped refrigerated; freezing lyses red blood cells and degrades analytes.
ER Red Flags — Seek Immediate Medical Attention
- Newborn exhibits persistent lethargy, poor feeding, or projectile vomiting — possible metabolic crisis.
- Unexplained seizures, hypotonia (floppy baby), or high-pitched crying in the neonatal period.
- Signs of acute metabolic decompensation: tachypnea, hypothermia, or altered consciousness.
- Abnormal newborn screening result reported — contact your neonatologist immediately for urgent confirmatory testing and metabolic consult.
Pre-Test Requirements & Sample Logistics
- Sample Type: One drop of heel-prick blood applied to each of 3 designated spots on filter paper (provided by LPL).
- Transport: Ship refrigerated at 2–8°C. DO NOT FREEZE. Freezing causes hemolysis and invalidates results.
- Documentation: Complete clinical details and comprehensive drug/supplement history must accompany the sample. Any unreported medications, herbal supplements, or maternal medications (if breastfeeding) must be disclosed.
- Collection Schedule: Samples accepted Monday, Wednesday, and Friday by 9 AM. Report delivered the next day.
- Home Collection: VIP Mobile Phlebotomy available 8 AM – 11 PM daily. Cold-chain transport maintained throughout.
Frequently Asked Questions
What conditions does the Comprehensive Newborn Screening Panel detect, and why is early detection critical?
This panel detects over 50 inborn errors of metabolism including phenylketonuria (PKU), maple syrup urine disease (MSUD), congenital hypothyroidism, congenital adrenal hyperplasia (CAH), galactosemia, and medium-chain acyl-CoA dehydrogenase (MCAD) deficiency — conditions where early dietary or hormonal intervention can prevent irreversible neurological damage and save lives. يكشف هذا الفحص عن أكثر من 50 اضطراباً استقلابياً وراثياً، والتدخل المبكر يمنع الضرر العصبي الدائم وينقذ الأرواح.
How is the blood sample collected from my newborn, and is it painful?
A rapid heel-prick collects a few drops of capillary blood onto specialized filter paper — the procedure is minimally invasive, completed in under 60 seconds, and causes only momentary discomfort comparable to a quick pinprick. يتم جمع العينة عبر وخز كعب القدم بسرعة وأمان، وهو إجراء بسيط لا يستغرق سوى ثوانٍ معدودة.
When will I receive the results, and who interprets them for clinical decision-making?
Results are delivered the next day when samples are collected on Monday, Wednesday, or Friday by 9 AM, and interpretation is provided by a DHA-licensed pediatrician or neonatologist with telephonic clinical guidance included for all patients. تصدر النتائج في اليوم التالي ويقوم بتفسيرها طبيب أطفال أو طبيب حديثي ولادة مرخص من هيئة الصحة بدبي مع استشارة هاتفية شاملة.
Regulatory Compliance: This laboratory operates under UAE Federal Decree-Law No. 41 of 2024 (Art. 87), the CDS Law 2026 (Minors Protection Provisions), and the UAE Personal Data Protection Law (PDPL). All patient data is processed in full compliance with UAE healthcare data privacy mandates.
Accreditation: ISO 9001:2015 Certified (Certificate No. INT/EGQ/2509DA/3139). DHA Facility License No. 9834453.
Medical Disclaimer: This newborn screening panel is a screening, not a diagnostic confirmation. Abnormal results require confirmatory testing and clinical correlation by a licensed physician. Do not delay seeking emergency care based on screening timelines.
For appointments, insurance verification, or clinical inquiries, contact us via WhatsApp: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians